NCT06246643 2026-03-19A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer StudiesBayerPhase 2 Active not recruiting13 enrolled
NCT04757363 2026-03-04A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric CancerMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting39 enrolled